Table 4 Cell viability (%) after 24 h and 48 h treatments.

From: Hyaluronic acid–chitosan conjugated PLGA nanoparticles for dual chemo-photothermal therapy of triple-negative breast cancer

Treatment

24 h viability (%)

48 h viability (%)

Control

100 ± 1.1

100 ± 0.9

Free DOX

68.7 ± 2.3

54.3 ± 2.2

Free ICG + NIR

72.1 ± 2.0

61.8 ± 1.9

DOX/ICG NPs

56.5 ± 2.1

43.9 ± 1.7

HA–CS–PLGA–DOX/ICG NPs

44.2 ± 1.8

31.7 ± 1.5

HA–CS–PLGA–DOX/ICG + NIR

25.1 ± 1.3

13.5 ± 1.0

Back to article page